Skip to main content
Premium Trial:

Request an Annual Quote

EU Regulators Approve Jurilab, Nanogen s Drug Metabolism Chip as IVD

NEW YORK, May 2 (GenomeWeb News) - European regulators have granted CE Mark approval to Jurilab and Nanogen's DrugMet drug-metabolizing enzyme microarray, the companies said today.

 

The firms can now sell the product in the European Union for clinical use as an in vitro diagnostic.

 

Launched in 2004 as a research-use product, DrugMet is designed to detect variation in genes including CYP2D6, CYP2C9, and CYP2C19, as well as duplication and deletion of the CYP2D6 gene.

 

In July, Nanogen paid €1.25 million ($1.5 million) for a 25-percent stake in Jurilab.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.